Lack of anti-GOR antibody among subjects with GB virus C/hepatitis G virus RNA

Homologies were sought between the putative amino acid sequences of GB virus C/hepatitis G virus (GBV‐C/HGV) and the GOR epitope or the liver/kidney microsome‐1 (LKM‐1) epitope, which share partial sequence identity with the hepatitis C virus (HCV) polyprotein. Anti‐GOR antibody (anti‐GOR) was assay...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical virology Vol. 55; no. 2; pp. 129 - 133
Main Authors Nakano, Tatsunori, Mizokami, Masashi, Cao, Kun, Noguchi, Seiji, Sata, Michio, Park, Young-Min, Kim, Boo-Sung, Oyunsuren, Tsendsuren, Pereira, Leila Beltrao, Ruzibakiev, Ruslan, Gurtsevitch, Vladimir, Hayami, Masanori
Format Journal Article
LanguageEnglish
Published New York Wiley Subscription Services, Inc., A Wiley Company 01.06.1998
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Homologies were sought between the putative amino acid sequences of GB virus C/hepatitis G virus (GBV‐C/HGV) and the GOR epitope or the liver/kidney microsome‐1 (LKM‐1) epitope, which share partial sequence identity with the hepatitis C virus (HCV) polyprotein. Anti‐GOR antibody (anti‐GOR) was assayed among 100 subjects with GBV‐C/HGV RNA. Twenty‐one and 25 subjects were coinfected with hepatitis B virus (HBV) or HCV, respectively. Homologies were found between the NS5 or E2 polyproteins of GBV‐C/HGV and the GOR epitope or the LKM‐1 epitope, respectively. These segments of GBV‐C/HGV polyproteins sharing identity with the GOR or the LKM‐1 epitope were well conserved among three genotypes of GBV‐C/HGV. However, only 1 of 55 subjects (1.8%) with GBV‐C/HGV RNA, but not with HBV or HCV, was positive for anti‐GOR. The positivity for anti‐GOR among the group with GBV‐C/HGV RNA alone was significantly lower than that among the groups with HCV RNA (P < 0.01 and P < 0.05, respectively). Only 2 of 55 subjects (3.6%) with GBV‐C/HGV RNA alone exhibited elevation of alanine aminotransferase. The incidence of liver dysfunction among the group with GBV‐C/HGV RNA alone was significantly lower than the incidence among the groups with GBV‐C/HGV RNA and hepatitis B surface antigen (HBsAg) or HCV RNA (P < 0.01 and P < 0.01, respectively). These data indicate that 1) there is no association between GBV‐C/HGV infection and the presence of anti‐GOR, and 2) GBV‐C/HGV infection is not related to chronic liver dysfunction. J. Med. Virol. 55:129–133, 1998. © 1998 Wiley‐Liss, Inc.
Bibliography:Ministry of Education, Science, and Culture of Japan
istex:40ABC2CBE15143AC0CD3CD3852BEC0CCC8B55A7A
ArticleID:JMV8
Viral Hepatitis Research Foundation of Japan
Ministry of Health and Welfare of Japan
ark:/67375/WNG-5DV1RL7K-W
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0146-6615
1096-9071
DOI:10.1002/(SICI)1096-9071(199806)55:2<129::AID-JMV8>3.0.CO;2-4